Fasken is delighted to be attending the BIO International Convention, taking place from June 22 to 25, 2026, in San Diego, California.
The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full global biotech ecosystem and attracting 20,000 industry leaders. It brings together stakeholders from pharmaceutical companies, biotech startups, academia, non-profit organizations and government agencies.
Fasken’s team will be on site during the event to connect with our colleagues in the biotech community from across the globe.
About Fasken’s Life Sciences Team
Fasken’s Life Sciences team provides comprehensive support to life sciences clients throughout their lifecycle. Whether you’re a biotech startup, entering clinical trials, scaling up, expanding to new markets or exploring exit strategies, our team speaks your language. We know the unique challenges biotech and pharma companies face in securing and enforcing your patent portfolio, bringing a product to market, complying with Canada’s regulations, or raising funds across a competitive landscape. We have knowledgeable practitioners with advanced degrees in pharmaceutical sciences, clinical pharmacology, toxicology, and genetics. We know the sector.
Fasken lawyers and agents collaborate with our clients to provide advice tailored to your needs including marketing and product labelling, IP drafting and enforcement, competition, tax, litigation, contracts and agreements and a full range of corporate services from financings to M&A. Navigate complex challenges and bring your products to market in Canada with a team dedicated to your success. With a strong legal network in 47 countries, we also continue to be at the forefront of life sciences advancement and interests globally.
Fasken is ranked Band 1 by Chambers Canada for Life Sciences and is the most recognized Firm on The Globe & Mail’s list of Canada’s Best Law Firms 2025, being included in every category of Corporate Law and in Healthcare & Life Sciences and Intellectual Property.
For more information about Fasken’s Life Sciences Group, please contact Lina A. Lafortune at [email protected]
